Matthew Frohn

Matthew has over twenty years’ experience as a life science venture investor. As co-founder of Longwall Venture Partners, he has been involved as investor and board director in a range of healthcare and life science technology businesses including medical devices, molecular diagnostics, drug delivery systems, discovery tools and vaccines. He has a D.Phil in Biochemistry from the University of Oxford and pre-venture experience in clinical pathology, virology and drug development.